Full-text source covering federal and state laws and regulations and court decisions that govern the safety, effectiveness, purity, packaging and labeling of food, drugs and cosmetics. Devoted primarily to the Federal Food, Drug and Cosmetic Act, the Fair Packaging and Labeling Act and the Comprehensive Drug Prevention and Control Act.
Learn More »Interested biologics facilities are invited to participate in the FDA's Center for Biologics Evaluation and Research (CBER) Regulatory Site Visit Training Program. The training program will give CBER regulatory review, compliance, and other staff an opportunity to visit biologics facilities. The visits are intended to allow CBER staff to directly observe routine manufacturing practices and to give the staff a better understanding of the biologics industry, including its challenges and operations. Written or electronic requests for participation, including a description of the facility relative to products regulated by CBER, should be submitted by March 11, 2010. FDA Notice. Read More
For more information regarding this topic, see the Food, Drug and Cosmetics Law Reporter. The Reporter provides the full-text source covering federal and state laws and regulations and court decisions that govern the safety, effectiveness, purity, packaging and labeling of food, drugs and cosmetics. Devoted primarily to the Federal Food, Drug and Cosmetic Act, the Fair Packaging and Labeling Act and the Comprehensive Drug Prevention and Control Act. Learn more.
Food, Drug and Cosmetics Law Reporter
Everything you need to know about Food and Drug Regulations.Full-text source covering federal and state laws and regulations and court decisions that govern the safety, effectiveness, purity, packaging and labeling of food, drugs and cosmetics. Learn More » |
Medical Devices ReporterAccess the full text plus expert analysis of all laws and regulations governing the classification, approval, manufacture, and marketing of all medical diagnostic, and radiological devices. Learn More » |
